Shanghai Hile Bio-Technology Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 4/6
Shanghai Hile Bio-Technology has a total shareholder equity of CN¥1.2B and total debt of CN¥60.9M, which brings its debt-to-equity ratio to 5%. Its total assets and total liabilities are CN¥1.6B and CN¥398.0M respectively.
Anahtar bilgiler
5.0%
Borç/özkaynak oranı
CN¥60.91m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | CN¥221.20m |
| Eşitlik | CN¥1.23b |
| Toplam yükümlülükler | CN¥398.05m |
| Toplam varlıklar | CN¥1.62b |
Son finansal sağlık güncellemeleri
Güncelleme yok
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 603718's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥371.0M).
Uzun Vadeli Yükümlülükler: 603718's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥27.0M).
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 603718 has more cash than its total debt.
Borcun Azaltılması: 603718's debt to equity ratio has increased from 0% to 5% over the past 5 years.
Borç Kapsamı: 603718's debt is well covered by operating cash flow (116.2%).
Faiz Kapsamı: Insufficient data to determine if 603718's interest payments on its debt are well covered by EBIT.